Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 19,552 | 21,762 | 40,795 | 84,314 | 22,086 |
| Cost of Goods | 10,068 | 11,134 | 21,054 | 46,740 | 9,960 |
| Gross Profit | 9,484 | 10,628 | 19,741 | 37,574 | 12,126 |
| Operating Expenses | 42,490 | 36,459 | 52,765 | 96,408 | 39,785 |
| Operating Income | -32,938 | -25,697 | -32,970 | -58,094 | -26,699 |
| Interest Expense | 10 | 9 | 2 | 572 | 853 |
| Other Income | 48 | 7,424 | 6,788 | -411 | 5,751 |
| Pre-tax Income | -32,900 | -18,282 | -26,184 | -59,077 | -21,801 |
| Income Tax | -1,216 | -609 | -151 | 288 | 118 |
| Net Income Continuous | -31,684 | -17,673 | -26,033 | -59,365 | -21,919 |
| Net Income Discontinuous | -3,003 | -15,786 | N/A | N/A | -5,019 |
| Net Income | $-34,687 | $-33,459 | $-26,033 | $-34,072 | $-26,938 |
| EPS Basic Total Ops | -0.09 | -0.09 | -0.07 | -0.06 | -0.07 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.07 | -0.15 | -0.06 |
| EPS Basic Discontinuous Ops | -0.01 | -0.04 | N/A | N/A | -0.01 |
| EPS Diluted Total Ops | -0.09 | -0.09 | -0.07 | -0.06 | -0.07 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.07 | -0.15 | -0.06 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.04 | N/A | N/A | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.05 | -0.06 | -0.07 | -0.06 |
| EBITDA(a) | $-32,028 | $-22,433 | $-29,640 | $-55,273 | $-24,600 |